Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Fierce Pharma
US reveals new Medicare prices for second round of IRA drugs
The U.S. has revealed price reductions for 15 prescription drugs negotiated by Medicare through the IRA, headlined by Novo Nordisk's semaglutide.
Kevin Dunleavy
Nov 26, 2025 11:42am
Fierce Pharma
Cigna files anti-competition lawsuit against BMS over Pomalyst
Jun 25, 2025 8:50am
Hospitals cheer 340B rebate ruling but await HHS' final say
May 16, 2025 4:55pm
RFK Jr.'s HHS picks up Biden admin fight against 340B rebates
Mar 18, 2025 4:45pm
Bristol Myers latest pharma to sue HHS over 340B rebate model
Dec 3, 2024 7:30am
Lawmakers, policy experts spar over the Inflation Reduction Act
Sep 17, 2024 3:30pm
